Cannabis and Acne
What the evidence actually says about cannabinoids, CBD, and topical hemp products for acne vulgaris.
Acne is one of the most over-hyped uses of CBD in skincare marketing. The biology is genuinely interesting — cannabinoids can dampen sebum production and inflammation in lab dishes — but human evidence is thin. One small clinical study and a pile of in-vitro work do not justify the 'CBD clears acne' claims plastered on serums. If your acne is moderate or severe, see a dermatologist. Tretinoin, benzoyl peroxide, and adapalene have decades of trial data. Cannabinoids do not.
Plain-language summary
Acne is caused by a mix of excess sebum (skin oil), clogged hair follicles, the bacterium Cutibacterium acnes, and inflammation. Cannabinoids — especially CBD — interact with skin cells through the endocannabinoid system, which is genuinely present in sebaceous glands [1] Strong evidence. In lab experiments, CBD reduced sebum production and inflammation in cultured human sebocytes [2] Strong evidence.
That is not the same as 'CBD treats acne in people.' Only a handful of small human studies exist, and most CBD skincare products on the market have never been tested in any clinical trial. If a product works for your skin, great — but the marketing claims are running far ahead of the science.
This article is not medical advice. If you have persistent, painful, or scarring acne, see a dermatologist.
What probably works
Honestly: nothing in the cannabis category reaches 'probably works' for acne by the standards we use for other treatments. There is no cannabinoid product with the kind of repeated, large-scale randomized trial evidence that supports retinoids or benzoyl peroxide No data.
The closest thing to a positive human signal is a 2019 open-label study of a 3% cannabis seed extract cream applied to the cheeks for 12 weeks, which reported reductions in sebum and erythema [3] Weak / limited. It was small, unblinded, and not replicated. Treat it as a hint, not proof.
What might work
Topical CBD for mild inflammatory acne. The mechanistic case is reasonable: CBD reduced lipogenesis in human sebocytes and suppressed pro-inflammatory cytokines in vitro [2][evidence:strong for mechanism, weak for clinical effect]. CBG and CBC showed similar sebostatic effects in follow-up sebocyte work [4] Weak / limited. None of this has been confirmed in a properly powered randomized human trial.
Hemp seed oil as a non-comedogenic moisturizer. Hemp seed oil contains no meaningful cannabinoids but has a favorable linoleic-to-oleic acid ratio, which is plausibly helpful in acne-prone skin where linoleic acid in sebum is often low [5] Weak / limited. This is a 'gentle moisturizer' claim, not an acne treatment claim.
Cannabidiolic acid (CBDA) and other minor cannabinoids. Interesting preclinical data, no human acne trials No data.
What doesn't work or has weak evidence
- Smoking or vaping cannabis to clear acne. No evidence. Cannabis use is associated with increased appetite (often for high-glycemic foods, which can worsen acne), stress patterns, and disrupted sleep, all of which can plausibly make acne worse rather than better [evidence:none for benefit; weak for harm].
- Oral CBD for acne. No clinical trials. Marketing claims here are pure folklore No data.
- CBD for acne scars. Despite confident TikTok claims, no controlled human data exists for cannabinoids improving atrophic or hypertrophic acne scars No data.
- 'Full-spectrum entourage effect' acne serums. The entourage effect itself is plausible for some endpoints but remains [disputed] in general, and has zero specific evidence for acne No data.
- THC topicals for acne. No human studies. Mechanistically less attractive than CBD because THC can be pro-lipogenic in sebocytes at some doses [2] Weak / limited.
What we don't know
We don't know:
- The optimal concentration of CBD for topical acne use. Products range from 0.1% to over 5% with no comparative data.
- Whether CBD penetrates deeply enough through the stratum corneum at typical formulations to reach sebaceous glands in meaningful amounts.
- Whether cannabinoids interact usefully (or harmfully) with standard acne treatments like tretinoin or benzoyl peroxide. Benzoyl peroxide is a strong oxidizer and likely degrades CBD on contact.
- Long-term safety of daily topical cannabinoid use on facial skin over years.
- Whether oral cannabis use modulates androgens or insulin signaling in ways that affect acne — current human data are inconsistent Disputed.
Comparison with standard treatments
For context, here is what mainstream dermatology offers, all of which have far stronger evidence than any cannabinoid product:
- Topical retinoids (tretinoin, adapalene, tazarotene): First-line for most acne. Decades of RCT data [6] Strong evidence. Adapalene 0.1% is available over the counter in the US.
- Benzoyl peroxide: Kills C. acnes, no resistance development. Strong evidence [6] Strong evidence.
- Topical and oral antibiotics: Effective but used short-term to avoid resistance [6] Strong evidence.
- Hormonal therapy (combined oral contraceptives, spironolactone): Effective for hormonal acne in patients who can take them [7] Strong evidence.
- Isotretinoin: Highly effective for severe nodulocystic acne; requires monitoring [6] Strong evidence.
Cannabinoid products do not currently compete with any of these on evidence. They may have a role as adjuncts for skin comfort or as alternatives for patients who can't tolerate first-line treatments, but that role is speculative.
Risks and side effects
Topical CBD is generally well tolerated in short-term studies, with contact dermatitis being the main reported issue [8] Weak / limited. Specific concerns for acne use:
- Carrier oils matter more than the CBD. Many CBD serums use coconut oil (MCT), which is comedogenic for some people. The product may make acne worse for reasons unrelated to cannabinoids.
- Product quality varies wildly. Independent testing has repeatedly found CBD products mislabeled by 50% or more in either direction, and some contain pesticide residues or heavy metals [9] Strong evidence.
- Drug interactions are mostly a concern for oral CBD, not topicals, but high-dose topical use over large body surface area has not been well studied.
- Delayed real treatment. The biggest risk of relying on cannabinoid skincare for moderate-to-severe acne is the months you lose before starting a treatment that actually works. Acne scarring is largely preventable with early effective treatment.
This article is not medical advice. Talk to a dermatologist or qualified clinician about your specific situation.
Sources
- Peer-reviewed Bíró T, Tóth BI, Haskó G, Paus R, Pacher P. The endocannabinoid system of the skin in health and disease: novel perspectives and therapeutic opportunities. Trends in Pharmacological Sciences. 2009;30(8):411-420.
- Peer-reviewed Oláh A, Tóth BI, Borbíró I, et al. Cannabidiol exerts sebostatic and antiinflammatory effects on human sebocytes. Journal of Clinical Investigation. 2014;124(9):3713-3724.
- Peer-reviewed Ali A, Akhtar N. The safety and efficacy of 3% Cannabis seeds extract cream for reduction of human cheek skin sebum and erythema content. Pakistan Journal of Pharmaceutical Sciences. 2015;28(4):1389-1395. ↗
- Peer-reviewed Oláh A, Markovics A, Szabó-Papp J, et al. Differential effectiveness of selected non-psychotropic phytocannabinoids on human sebocyte functions implicates their introduction in dry/seborrhoeic skin and acne treatment. Experimental Dermatology. 2016;25(9):701-707.
- Peer-reviewed Callaway J, Schwab U, Harvima I, et al. Efficacy of dietary hempseed oil in patients with atopic dermatitis. Journal of Dermatological Treatment. 2005;16(2):87-94.
- Peer-reviewed Zaenglein AL, Pathy AL, Schlosser BJ, et al. Guidelines of care for the management of acne vulgaris. Journal of the American Academy of Dermatology. 2016;74(5):945-973.
- Peer-reviewed Arowojolu AO, Gallo MF, Lopez LM, Grimes DA. Combined oral contraceptive pills for treatment of acne. Cochrane Database of Systematic Reviews. 2012;(7):CD004425.
- Peer-reviewed Eagleston LRM, Kalani NK, Patel RR, Flaten HK, Dunnick CA, Dellavalle RP. Cannabinoids in dermatology: a scoping review. Dermatology Online Journal. 2018;24(6). ↗
- Peer-reviewed Bonn-Miller MO, Loflin MJE, Thomas BF, Marcu JP, Hyke T, Vandrey R. Labeling Accuracy of Cannabidiol Extracts Sold Online. JAMA. 2017;318(17):1708-1709.
How this page was made
Generation history
Drafting assistance and fact-check automation are used, with a human operator spot-checking on a weekly basis. See how articles are made.